LINC02242

Across TCGA pan-cancer cohorts, LINC02242 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC02242’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02242 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02242 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

BRCA, THCA, and LUAD are the cancer types where LINC02242 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02242 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.462	<.001	6	view →
THCA	Male	All	−0.342	<.001	6	view →
LUAD	All	II,III,IV	−0.145	.010	6	view →
KIRC	Male	All	+0.094	.005	6	view →
LIHC	All	All	+0.094	.007	4	view →
BLCA	All	All	+0.286	.048	2	view →
PRAD	All	All	−0.263	<.001	2	view →
COAD	All	IV	+0.194	.039	2	view →
UCEC	All	All	−0.137	.017	2	view →
KICH	All	All	−0.089	.026	2	view →
STAD	Male	II,III,IV	−0.125	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC02242–BRCA

Open the BRCA breakdown →